Multiphasic triacylglycerol dynamics in the intact heart during acute in vivo overexpression of CD36

Journal of Lipid Research

Volumn 54, Issue 1, 2013, Pages 97-106

  Carley, Andrew N ^a,b   Bi, Jian ^a,b   Wang, Xuerong ^a,b   Banke, Natasha H ^a,b   Dyck, Jason R B ^c   O'Donnell, J Michael ^a,b   Lewandowski, E Douglas ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Fatty acids; Nuclear magnetic resonance; Triglycerides

Indexed keywords

ACETYL COENZYME A; ADENOVIRUS VECTOR; ADIPOSE TRIGLYCERIDE LIPASE; CD36 ANTIGEN; DIACYLGLYCEROL ACYLTRANSFERASE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LONG CHAIN FATTY ACID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; FATTY ACID TRANSPORT; GENE EXPRESSION REGULATION; HEART; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; IN VIVO STUDY; ISOLATED HEART; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYL COENZYME A; ADENOVIRIDAE; ANIMALS; ANTIGENS, CD36; BIOLOGICAL TRANSPORT; FATTY ACIDS; GENE EXPRESSION; HEK293 CELLS; HUMANS; KINETICS; LIPOLYSIS; MYOCARDIUM; RATS; TRIGLYCERIDES;

EID: 84871227958     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M029991     Document Type: Article

References (50)

1. Banke, N. H., A. R. Wende, T. C. Leone, J. M. O'Donnell, E. D. Abel, D. P. Kelly, and E. D. Lewandowski. 2010. Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha. Circ. Res. 107: 233-241.
2. O'Donnell, J. M., A. D. Fields, N. Sorokina, and E. D. Lewandowski. 2008. The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover. J. Mol. Cell. Cardiol. 44: 315-322.
3. O'Donnell, J. M., M. Zampino, N. M. Alpert, M. J. Fasano, D. L. Geenen, and E. D. Lewandowski. 2006. Accelerated triacylglycerol turnover kinetics in hearts of diabetic rats include evidence for compartmented lipid storage. Am. J. Physiol. Endocrinol. Metab. 290: E448-E455. (Pubitemid 43671690)
4. Haemmerle, G., T. Moustafa, G. Woelkart, S. Buttner, A. Schmidt, T. van de Weijer, M. Hesselink, D. Jaeger, P. C. Kienesberger, K. Zierler, et al. 2011. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nat. Med. 17: 1076-1085.
5. Saddik, M., and G. D. Lopaschuk. 1991. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J. Biol. Chem. 266: 8162-8170. (Pubitemid 21906491)
6. Listenberger, L. L., X. Han, S. E. Lewis, S. Cases, R. V. Farese, Jr., D. S. Ory, and J. E. Schaffer. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA. 100: 3077-3082. (Pubitemid 36356542)
7. Liu, L., X. Shi, K. G. Bharadwaj, S. Ikeda, H. Yamashita, H. Yagyu, J. E. Schaffer, Y. H. Yu, and I. J. Goldberg. 2009. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. J. Biol. Chem. 284: 36312-36323.
8. Lehman, J. J., S. Boudina, N. H. Banke, N. Sambandam, X. Han, D. M. Young, T. C. Leone, R. W. Gross, E. D. Lewandowski, E. D. Abel, et al. 2008. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am. J. Physiol. Heart Circ. Physiol. 295: H185-H196.
9. Huss, J. M., and D. P. Kelly. 2005. Mitochondrial energy metabolism in heart failure: a question of balance. J. Clin. Invest. 115: 547-555. (Pubitemid 40322224)
10. Pound, K. M., N. Sorokina, K. Ballal, D. A. Berkich, M. Fasano, K. F. Lanoue, H. Taegtmeyer, J. M. O'Donnell, and E. D. Lewandowski. 2009. Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy. Circ. Res. 104: 805-812.
11. Kampf, J. P., and A. M. Kleinfeld. 2007. Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane. Physiology (Bethesda). 22: 7-14.
12. Bonen, A., A. Chabowski, J. J. Luiken, and J. F. Glatz. 2007. Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence. Physiology (Bethesda). 22: 15-29.
13. Hamilton, J. A. 2007. New insights into the roles of proteins and lipids in membrane transport of fatty acids. Prostaglandins Leukot. Essent. Fatty Acids. 77: 355-361. (Pubitemid 350198863)
14. Goldberg, I. J., R. H. Eckel, and N. A. Abumrad. 2009. Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. J. Lipid Res. 50 (Suppl.): S86-S90.
15. Carley, A. N., and A. M. Kleinfeld. 2011. Fatty acid (FFA) transport in cardiomyocytes revealed by imaging unbound FFA is mediated by an FFA pump modulated by the CD36 protein. J. Biol. Chem. 286: 4589-4597.
16. Ikeda, Y., Y. Gu, Y. Iwanaga, M. Hoshijima, S. S. Oh, F. J. Giordano, J. Chen, V. Nigro, K. L. Peterson, K. R. Chien, et al. 2002. Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer. Circulation. 105: 502-508. (Pubitemid 34141709)
17. O'Donnell, J. M., and E. D. Lewandowski. 2005. Efficient, cardiac-specific adenoviral gene transfer in rat heart by isolated retrograde perfusion in vivo. Gene Ther. 12: 958-964. (Pubitemid 40903417)
18. O'Donnell, J. M., A. Fields, X. Xu, S. A. Chowdhury, D. L. Geenen, and J. Bi. 2008. Limited functional and metabolic improvements in hypertrophic and healthy rat heart overexpressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo. Am. J. Physiol. Heart Circ. Physiol. 295: H2483-H2494.
19. O'Donnell, J. M., K. Pound, X. Xu, and E. D. Lewandowski. 2009. SERCA1 expression enhances the metabolic efficiency of improved contractility in post-ischemic heart. J. Mol. Cell. Cardiol. 47: 614-621.
20. Abumrad, N. A., M. R. el-Maghrabi, E. Z. Amri, E. Lopez, and P. A. Grimaldi. 1993. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268: 17665-17668. (Pubitemid 23260267)
21. Ibrahimi, A., Z. Sfeir, H. Magharaie, E. Z. Amri, P. Grimaldi, and N. A. Abumrad. 1996. Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport. Proc. Natl. Acad. Sci. USA. 93: 2646-2651. (Pubitemid 26114302)
22. O'Donnell, J. M., N. M. Alpert, L. T. White, and E. D. Lewandowski. 2002. Coupling of mitochondrial fatty acid uptake to oxidative flux in the intact heart. Biophys. J. 82: 11-18. (Pubitemid 34289777)
23. Lewandowski, E. D., C. Doumen, L. T. White, K. F. LaNoue, L. A. Damico, and X. Yu. 1996. Multiplet structure of 13C NMR signal from glutamate and direct detection of tricarboxylic acid (TCA) cycle intermediates. Magn. Reson. Med. 35: 149-154.
24. Sullards, M. C., J. C. Allegood, S. Kelly, E. Wang, C. A. Haynes, H. Park, Y. Chen, and A. H. Merrill, Jr. 2007. Structure-specific, quantitative methods for analysis of sphingolipids by liquid chromatography-tandem mass spectrometry: "inside-out" sphingolipidomics. Methods Enzymol. 432: 83-115.
25. Koonen, D. P., M. Febbraio, S. Bonnet, J. Nagendran, M. E. Young, E. D. Michelakis, and J. R. Dyck. 2007. CD36 expression contributes to age-induced cardiomyopathy in mice. Circulation. 116: 2139-2147. (Pubitemid 350060351)
26. Kienesberger, P. C., T. Pulinilkunnil, M. M. Sung, J. Nagendran, G. Haemmerle, E. E. Kershaw, M. E. Young, P. E. Light, G. Y. Oudit, R. Zechner, et al. 2012. Myocardial ATGL overexpression decreases the reliance on fatty acid oxidation and protects against pressure overload-induced cardiac dysfunction. Mol. Cell. Biol. 32: 740-750.
27. McCullagh, K. J., R. C. Poole, A. P. Halestrap, K. F. Tipton, M. O'Brien, and A. Bonen. 1997. Chronic electrical stimulation increases MCT1 and lactate uptake in red and white skeletal muscle. Am. J. Physiol. 273: E239-E246.
28. Liu, Q., A. K. Zaiss, P. Colarusso, K. Patel, G. Haljan, T. J. Wickham, and D. A. Muruve. 2003. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Hum. Gene Ther. 14: 627-643. (Pubitemid 36543435)
29. O'Donnell, J., A. Fields, X. Xu, and E. Lewandowski. 2007. Metabolic and functional response of failing heart to adrenergic stimulation following SERCA1 overexpression. J. Mol. Cell. Cardiol. 42: S132-S133.
30. Banke, N. H., L. Yan, K. M. Pound, S. Dhar, H. Reinhardt, M. S. De Lorenzo, S. F. Vatner, and E. D. Lewandowski. 2012. Sexual dimorphism in cardiac triacylglyceride dynamics in mice on long term caloric restriction. J. Mol. Cell. Cardiol. 52: 733-740.
31. Haemmerle, G., A. Lass, R. Zimmermann, G. Gorkiewicz, C. Meyer, J. Rozman, G. Heldmaier, R. Maier, C. Theussl, S. Eder, et al. 2006. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 312: 734-737.
32. Liu, L., S. Yu, R. S. Khan, G. P. Ables, K. G. Bharadwaj, Y. Hu, L. A. Huggins, J. W. Eriksson, L. K. Buckett, A. V. Turnbull, et al. 2011. DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle. J. Lipid Res. 52: 732-744.
33. Liu, L., S. Yu, R. S. Khan, S. Homma, P. C. Schulze, W. S. Blaner, Y. Yin, and I. J. Goldberg. 2012. Diacylglycerol acyl transferase 1 overexpression detoxifies cardiac lipids in PPARgamma transgenic mice. J. Lipid Res. 53: 1482-1492.
34. Chakravarthy, M. V., I. J. Lodhi, L. Yin, R. R. Malapaka, H. E. Xu, J. Turk, and C. F. Semenkovich. 2009. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell. 138: 476-488.
35. Madrazo, J. A., and D. P. Kelly. 2008. The PPAR trio: regulators of myocardial energy metabolism in health and disease. J. Mol. Cell. Cardiol. 44: 968-975.
36. Ouwens, D. M., M. Diamant, M. Fodor, D. D. Habets, M. M. Pelsers, M. El Hasnaoui, Z. C. Dang, C. E. van den Brom, R. Vlasblom, A. Rietdijk, et al. 2007. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia. 50: 1938-1948. (Pubitemid 47222854)
37. Ludwig, E. H., R. W. Mahley, E. Palaoglu, S. Ozbayrakci, M. E. Balestra, I. B. Borecki, T. L. Innerarity, and R. V. Farese, Jr. 2002. DGAT1 promoter polymorphism associated with alterations in body mass index, high density lipoprotein levels and blood pressure in Turkish women. Clin. Genet. 62: 68-73. (Pubitemid 36372699)
38. Bastie, C. C., T. Hajri, V. A. Drover, P. A. Grimaldi, and N. A. Abumrad. 2004. CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness. Diabetes. 53: 2209-2216. (Pubitemid 39145573)
39. Lauzier, B., C. Merlen, F. Vaillant, J. McDuff, B. Bouchard, P. C. Beguin, V. W. Dolinsky, S. Foisy, L. R. Villeneuve, F. Labarthe, et al. 2011. Post-translational modifications, a key process in CD36 function: lessons from the spontaneously hypertensive rat heart. J. Mol. Cell. Cardiol. 51: 99-108.
40. Augustus, A. S., J. Buchanan, T. S. Park, K. Hirata, H. L. Noh, J. Sun, S. Homma, J. D'Armiento, E. D. Abel, and I. J. Goldberg. 2006. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J. Biol. Chem. 281: 8716-8723. (Pubitemid 43847976)
41. Coort, S. L., D. M. Hasselbaink, D. P. Koonen, J. Willems, W. A. Coumans, A. Chabowski, G. J. van der Vusse, A. Bonen, J. F. Glatz, and J. J. Luiken. 2004. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes. 53: 1655-1663. (Pubitemid 38857021)
42. Holloway, G. P., L. A. Snook, R. J. Harris, J. F. Glatz, J. J. Luiken, and A. Bonen. 2011. In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation. J. Physiol. 589: 169-180.
43. Wang, P., S. G. Lloyd, H. Zeng, A. Bonen, and J. C. Chatham. 2005. Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats. Am. J. Physiol. Heart Circ. Physiol. 288: H2102-H2110. (Pubitemid 40604093)
44. Burgmaier, M., S. Sen, F. Philip, C. R. Wilson, C. C. Miller 3rd, M. E. Young, and H. Taegtmeyer. 2010. Metabolic adaptation follows contractile dysfunction in the heart of obese Zucker rats fed a highfat "Western" diet. Obesity (Silver Spring). 18: 1895-1901.
45. Irie, H., I. B. Krukenkamp, J. F. Brinkmann, G. R. Gaudette, A. E. Saltman, W. Jou, J. F. Glatz, N. A. Abumrad, and A. Ibrahimi. 2003. Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids. Proc. Natl. Acad. Sci. USA. 100: 6819-6824. (Pubitemid 36666663)
46. Kusaka, Y., T. Tanaka, F. Okamoto, F. Terasaki, Y. Matsunaga, H. Miyazaki, and K. Kawamura. 1995. Effect of sulfo-N-succinimidyl palmitate on the rat heart: myocardial long-chain fatty acid uptake and cardiac hypertrophy. J. Mol. Cell. Cardiol. 27: 1605-1612.
47. Heather, L. C., N. J. Howell, Y. Emmanuel, M. A. Cole, M. P. Frenneaux, D. Pagano, and K. Clarke. 2011. Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis. PLoS ONE. 6: e26326.
48. Heather, L. C., M. A. Cole, C. A. Lygate, R. D. Evans, D. J. Stuckey, A. J. Murray, S. Neubauer, and K. Clarke. 2006. Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart. Cardiovasc. Res. 72: 430-437. (Pubitemid 44665850)
49. Strøm, C. C., M. Aplin, T. Ploug, T. E. Christoffersen, J. Langfort, M. Viese, H. Galbo, S. Haunso, and S. P. Sheikh. 2005. Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy. FEBS J. 272: 2684-2695.
50. Dorn 2nd, G. W. 2007. The fuzzy logic of physiological cardiac hypertrophy. Hypertension. 49: 962-970.